Company news

Patrys Limited news in 2022

Patrys Limited's news releases, calls and decks from 2022, newest first.

View company

Response to ASX Price Query

December 14, 2022

Patrys Appoints Global Biotechnology Leader as Chairman - In Preparation for First Clinical Trial for Groundbreaking Cancer Therapy

November 18, 2022

Appendix 4C - Quarterly - 30 September 2022

October 27, 2022

PAT DX3 Crosses Blood Brain Barrier in Healthy Animals

October 16, 2022

Appendix 4E and 2022 Annual Report

August 30, 2022

PAT-DX1 From Engineering Run Meets all Specification Tests

August 29, 2022

New Research Grant For Deoxymabs in Metastatic Breast Cancer

August 26, 2022

PAT-DX1/Radiation Combination Improves Brain Cancer Survival

August 9, 2022

Appendix 4C - Quarterly - 30 June 2022

July 27, 2022

PAT-DX1 Engineering Run Successfully Completed

July 3, 2022

New Mechanism By Which PAT-DX1 May Reduce Cancer Metastasis

June 13, 2022

CBCF funding to support deoxymab brain cancer development

June 3, 2022

Appendix 4C - Quarterly - 31 March 2022

April 28, 2022

Application for quotation of securities - PAB

April 14, 2022

Stable Cell Line for Production of PAT-DX3 Established

February 27, 2022

Appendix 4D - Half Year Accounts - 31 December 2021

February 24, 2022

Appendix 4C - Quarterly - 31 December 2021

January 30, 2022

PAT-DX1 engineering update

January 23, 2022

Decks in 2022